Description

Semax is a synthetic peptide derived from a fragment of ACTH (adrenocorticotropic hormone), developed at the Russian Academy of Sciences. It has been studied for its potential neuroprotective and cognitive-modulating effects. Research published in journals such as Neuroscience and Behavioral Physiology suggests that Semax may influence the expression of BDNF (brain-derived neurotrophic factor) and modulate neurotransmitters such as dopamine and serotonin. Clinical studies conducted in Russia have investigated its use in post-stroke recovery, memory enhancement, focus, and cognitive performance. However, regulatory approval and clinical acceptance vary by country.